MedTrace Logo

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

NCT07091773 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-07-29

No results posted yet for this study

Summary

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

Conditions

  • Postoperative Pain Management During Rehabilitation in Patients Undergoing Total Knee Arthroplasty

Interventions

DEVICE

OLIZ Photobiomodulation Device

OLIZ device utilizes dual-wavelength technology combining specific red (660nm) and near-infrared (850nm) light parameters optimized for post-surgical tissue healing. The device features controlled power density, precise treatment duration protocols, and targeted application to knee arthroplasty surgical sites. Treatment parameters include specific irradiance levels, treatment session duration of 15 minutes, and 3 times of daily application frequency designed.

Sponsors & Collaborators

  • Inje University

    collaborator OTHER

  • InjeUniversityIlsanPaikHospital

    collaborator UNKNOWN

  • Gangnam Severance Hospital

    collaborator OTHER

  • National Medical Center, Seoul

    collaborator OTHER

  • National Health Insurance Service Ilsan Hospital

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • The Catholic University of Korea Uijeongbu St.Marys Hostpial

    collaborator UNKNOWN

  • LTBIO Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Kyung Wook Nha, M.D., Ph.D · Inje University Ilsan Paik Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-20
Primary Completion
2026-01-30
Completion
2026-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07091773 on ClinicalTrials.gov